Nature

Bayesian interim analysis and efficiency of phase III randomized trials

Improving efficiency of phase III trials is paramount for reducing costs, hastening approvals, and mitigating exposure to disadvantageous randomizations. Compared to standard frequentist interim ...
JD Supra

Frequentist or Bayesian? All Roads Lead to Smarter Trials with FDA’s New Bayesian Guidance

Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
MedPage Today

Are Bayesian Statistics Coming to a Clinical Trial Near You?

The FDA's move to incorporate Bayesian statistical methods into clinical trials of drugs and biologics garnered special treatment in JAMA this week. JAMA published three perspectives -- two welcoming ...
Nature

Comparative analysis of predictors of child mortality in Ethiopia via frequentist and Bayesian approaches

The child mortality rate is a leading factor in the well-being and development of a nation. It measures the quality of life for a given population. This study aimed to determine the effects of ...